Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2019

Nov 1, 2019

284_dirs_2019-11-01_140df597-e266-4c64-bedf-a7ab4199eeff.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-10-30

Reporting Person: Nally Michael (EVP, Chief Marketing Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-10-30 Common Stock M 2287.0000 $0.0000 Acquired 6195.7100 Direct
2019-10-30 Common Stock F 652.0000 $85.1000 Disposed 5543.7100 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-10-30 Restricted Stock Unit $ M 2287.0000 Disposed 2021-10-30 Common Stock (2287.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock - 401(k) Plan 1541.1159 Indirect

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Includes shares acquired and dividends earned through October 7, 2019, in the Merck U.S. Savings Plan, a 401(k) plan.

F3: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F4: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021.